TA
JNJ icon

Townsend & Associates’s Johnson & Johnson JNJ Stock Holding History

Townsend & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.3M Sell
9,246
-26
-0.3% -$6.06K 0.2% 56
2026
Q1 		$2.1M Sell
9,272
-234
-2% -$54.5K 0.18% 58
2025
Q4 		$2.09M Buy
9,506
+104
+1% +$20.6K 0.19% 57
2025
Q3 		$1.82M Sell
9,402
-313
-3% -$53.6K 0.17% 57
2025
Q2 		$1.64M Hold
9,715
– – 0.16% 59
2025
Q1 		$1.52M Sell
9,715
-270
-3% -$42.2K 0.16% 59
2024
Q4 		$1.48M Hold
9,985
– – 0.15% 58
2024
Q3 		$1.66M Sell
9,985
-212
-2% -$33.8K 0.17% 57
2024
Q2 		$1.64M Buy
10,197
+2,502
+33% +$372K 0.18% 55
2024
Q1 		$1.15M Sell
7,695
-95
-1% -$15.1K 0.13% 59
2023
Q4 		$1.24M Sell
7,790
-102
-1% -$15.6K 0.16% 59
2023
Q3 		$1.15M Buy
7,892
+2
+0% +$330 0.24% 58
2023
Q2 		$1.36M Buy
7,890
+462
+6% +$74.6K 0.35% 63
2023
Q1 		$1.22M Buy
7,428
+5,930
+396% +$958K 0.49% 66
2022
Q4 		$244K Buy
1,498
+2
+0.1% +$345 0.12% 95
2022
Q3 		$260K Buy
+1,496
New +$253K 0.12% 74
2021
Q2 		– Sell
-8,436
Closed -$1.39M – 69
2021
Q1 		$1.39M Sell
8,436
-189
-2% -$30.6K 0.9% 48
2020
Q4 		$1.36M Sell
8,625
-562
-6% -$82.9K 0.99% 48
2020
Q3 		$1.39M Sell
9,187
-4,610
-33% -$682K 1.09% 50
2020
Q2 		$1.94M Sell
13,797
-1,835
-12% -$267K 1.63% 14
2020
Q1 		$2.15M Sell
15,632
-61
-0.4% -$8.65K 2.23% 4
2019
Q4 		$2.27M Sell
15,693
-427
-3% -$57.9K 1.99% 7
2019
Q3 		$2.13M Buy
16,120
+29
+0.2% +$3.82K 2.03% 10
2019
Q2 		$2.29M Sell
16,091
-68
-0.4% -$9.41K 1.74% 15
2019
Q1 		$2.26M Sell
16,159
-158
-1% -$21.2K 2.28% 10
2018
Q4 		$2.11M Buy
16,317
+345
+2% +$48.1K 2.41% 10
2018
Q3 		$2.21M Buy
15,972
+203
+1% +$27K 2.18% 12
2018
Q2 		$1.91M Buy
15,769
+31
+0.2% +$3.87K 2.15% 18
2018
Q1 		$2.02M Buy
15,738
+2,987
+23% +$404K 1.61% 19
2017
Q4 		$1.78M Buy
+12,751
New +$1.78M 1.52% 18

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Townsend & Associates's JNJ Position: Q2 2026 in Review

Townsend & Associates reduced its Johnson & Johnson (JNJ) stake by 0.28% in Q2 2026, selling an estimated $6.06K and leaving 9,246 shares worth $2.3M. The position accounts for 0.2% of the portfolio, ranked #56.

Townsend & Associates first reported a position in JNJ in Q4 2017 and has held it in 30 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Townsend & Associates held 9,246 shares of Johnson & Johnson worth $2.3M as of Q2 2026.
  • Townsend & Associates sold 26 Johnson & Johnson shares in Q2 2026, an estimated $6.06K.
  • Johnson & Johnson made up 0.2% of Townsend & Associates's portfolio in Q2 2026, its #56 holding.
  • Townsend & Associates first reported a position in Johnson & Johnson in Q4 2017 and has held it in 30 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Townsend & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.